Search results
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
Gannett via AOL· 4 hours agoWhen releasing the data, Pfizer gave notice that there are variables that could change the future...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 4 hours agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 4 days agoYounger children, adults 65 and older...immunocompromised people may need multiple doses, the agency...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 5 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 5 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Another COVID vaccine? Yes, and here’s why
Denver Post· 6 days agoLast Wednesday, FDA’s advisers, a panel of physicians from hospitals and universities around the nation, unanimously voted to recommend a new vaccine. ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 6 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...